BGJ398 in Treating Patients With FGFR Positive Recurrent Head and Neck Cancer

Clinical trial NCT02706691 · TERMINATED

Trial details

NCT number: NCT02706691
Sponsor: University of Chicago
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

FGFR Gene Amplification FGFR1 Gene Amplification FGFR2 Gene Amplification FGFR2 Gene Mutation FGFR3 Gene Mutation Head and Neck Squamous Cell Carcinoma Human Papillomavirus Infection Recurrent Head and Neck Carcinoma Recurrent Nasopharynx Carcinoma Recurrent Oropharyngeal Squamous Cell Carcinoma

Start date: 2018-06-01
Primary completion: 2019-02-11
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.